Cue Biopharma Inc (CUE)
1.505
0.00 (0.00%)
USD |
NASDAQ |
Nov 14, 16:00
1.51
0.00 (0.00%)
After-Hours: 17:44
Cue Biopharma Free Cash Flow: -38.60M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -38.60M |
| March 31, 2024 | -38.97M |
| December 31, 2023 | -39.96M |
| September 30, 2023 | -39.52M |
| June 30, 2023 | -38.67M |
| March 31, 2023 | -41.21M |
| December 31, 2022 | -41.98M |
| September 30, 2022 | -42.11M |
| June 30, 2022 | -41.80M |
| March 31, 2022 | -38.91M |
| December 31, 2021 | -39.75M |
| September 30, 2021 | -36.21M |
| June 30, 2021 | -37.61M |
| March 31, 2021 | -34.59M |
| Date | Value |
|---|---|
| December 31, 2020 | -33.09M |
| September 30, 2020 | -32.43M |
| June 30, 2020 | -33.62M |
| March 31, 2020 | -33.29M |
| December 31, 2019 | -30.84M |
| September 30, 2019 | -28.41M |
| June 30, 2019 | -25.79M |
| March 31, 2019 | -26.33M |
| December 31, 2018 | -28.27M |
| September 30, 2018 | -26.11M |
| June 30, 2018 | -23.40M |
| March 31, 2018 | -19.76M |
| December 31, 2017 | -13.35M |
Free Cash Flow Range, Past 5 Years
-42.11M
Minimum
Sep 2022
-30.84M
Maximum
Dec 2019
-37.53M
Average
-38.67M
Median
Jun 2023
Free Cash Flow Benchmarks
| Biomarin Pharmaceutical Inc | 300.88M |
| Arbutus Biopharma Corp | -71.92M |
| GlycoMimetics Inc | -35.72M |
| FibroGen Inc | -202.99M |
| Cidara Therapeutics Inc | -125.11M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -9.99M |
| Cash from Investing (Quarterly) | -0.01M |
| Cash from Financing (Quarterly) | -1.00M |
| Free Cash Flow Per Share (Quarterly) | -0.1993 |
| Free Cash Flow to Equity (Quarterly) | -9.042M |
| Free Cash Flow Yield | -53.10% |